Clinical Trial Update: Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety of repeat intravitreal injections of jCell (human retinal progenitor cells) in adults with Retinitis Pigmentosa; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• jCell (human retinal progenitor cells)

Snippet

Sponsor: jCyte, Inc | Conditions: Retinitis Pigmentosa | Phase 2 | Status: COMPLETED | Results posted: 2023-09-26